Evaluation of Effect on High Intensity Focused Ultrasound (HIFU) for Treatment of Uterine Leiomyoma Using Contrast-Enhanced Ultrasonography
Xueming Liu
Abstract
Xueming Liu
Abstract
[Purpose] To assess the efficacy of high intensity focused ultrasound(HIFU) for the treatment of uterine leiomyoma using contrast-enhanced ultrasound imaging. [Methods] Thirty-two patients with 42 lesions of uterine leiomyoma were enrolled. All cases underwent contrast-enhanced ultrasonography (CEUS) before and after treatment, and all cases underwent CEUS again after treatment for 6 months. The patients were followed up from 6 to 12 months. [Results] Twenty-nine of the 42 lesions were found no enhancement in CEUS procedure, which indicated tumor necrosis. Mean uterine leiomyoma volume before treatment were 28.3 cm3 in this group. At 6-month follow-up, mean uterine leiomyoma volume decreased to 11.5 cm3 (P0.05). Twenty-nine lesions were found no enhancement too in CEUS procedure after treatment for 6 months and the area of no enhancement reduced. Mean uterine leiomyoma volume of 13 lesions which remained enhancement in CEUS procedure were 40.7cm3 and decreased to 36.5cm3 at 6-month follow-up (P0.05). The area which remained enhancement in CEUS procedure did not reduced after treatment for 6 months. Thirteen lesions were found. [Conclusion] CEUS can help to assess the therapeutic response of HIFU and indicate the position of residual tumors during the additional treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Purpose] To assess the efficacy of high intensity focused ultrasound(HIFU) for the treatment of uterine leiomyoma using contrast-enhanced ultrasound imaging. [Methods] Thirty-two patients with 42 lesions of uterine leiomyoma were enrolled. All cases underwent contrast-enhanced ultrasonography (CEUS) before and after treatment, and all cases underwent CEUS again after treatment for 6 months. The patients were followed up from 6 to 12 months. [Results] Twenty-nine of the 42 lesions were found no enhancement in CEUS procedure, which indicated tumor necrosis. Mean uterine leiomyoma volume before treatment were 28.3 cm3 in this group. At 6-month follow-up, mean uterine leiomyoma volume decreased to 11.5 cm3 (P0.05). Twenty-nine lesions were found no enhancement too in CEUS procedure after treatment for 6 months and the area of no enhancement reduced. Mean uterine leiomyoma volume of 13 lesions which remained enhancement in CEUS procedure were 40.7cm3 and decreased to 36.5cm3 at 6-month follow-up (P0.05). The area which remained enhancement in CEUS procedure did not reduced after treatment for 6 months. Thirteen lesions were found. [Conclusion] CEUS can help to assess the therapeutic response of HIFU and indicate the position of residual tumors during the additional treatment.
Key concepts: Medicine, Leiomyoma, Uterine leiomyoma, Contrast-enhanced ultrasound, Ultrasonography, Radiology, Ultrasound, High-intensity focused ultrasound